Cargando…
Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial
BACKGROUND: An increased rate of brain atrophy is often observed in older subjects, in particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain atrophy, cognitive impairment and dementia. Plasma concentrations of homocysteine can be lowered by dietary administratio...
Autores principales: | Smith, A. David, Smith, Stephen M., de Jager, Celeste A., Whitbread, Philippa, Johnston, Carole, Agacinski, Grzegorz, Oulhaj, Abderrahim, Bradley, Kevin M., Jacoby, Robin, Refsum, Helga |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935890/ https://www.ncbi.nlm.nih.gov/pubmed/20838622 http://dx.doi.org/10.1371/journal.pone.0012244 |
Ejemplares similares
-
Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
por: Oulhaj, Abderrahim, et al.
Publicado: (2016) -
Anti‐N‐homocysteine‐protein autoantibodies are associated with impaired cognition
por: Włoczkowska, Olga, et al.
Publicado: (2021) -
B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment
por: Jakubowski, Hieronim, et al.
Publicado: (2021) -
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
por: Perła-Kaján, Joanna, et al.
Publicado: (2021) -
Homocysteine and Dementia: An International Consensus Statement(1)
por: Smith, A. David, et al.
Publicado: (2018)